(3,3-DIFLUOROPYRROLIDIN-1-YL)-((2S,4S)-4-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)-1-((2R,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-2-YL)PYRROLIDIN-2-YL)METHANONE
UNII T71M9HVH8X
Substance Identification & Data
This profile provides standardized clinical and technical data for (3,3-difluoropyrrolidin-1-yl)-((2s,4s)-4-(4-pyrimidin-2-ylpiperazin-1-yl)-1-((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl)pyrrolidin-2-yl)methanone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T71M9HVH8X.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H34F2N6O6 XEPYKZIDLULSRS-OXZOJPPVSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3,3-difluoropyrrolidin-1-yl)-((2s,4s)-4-(4-pyrimidin-2-ylpiperazin-1-yl)-1-((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl)pyrrolidin-2-yl)methanone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.